UK markets closed
NIKKEI 225
38,236.07 -38.03 (-0.10%) HANG SENG
18,489.94 +14.02 (+0.08%) CRUDE OIL
78.38 +0.27 (+0.35%) GOLD FUTURES
2,322.00 +13.40 (+0.58%) DOW
38,675.68 +449.98 (+1.18%) Bitcoin GBP
51,130.88 +680.13 (+1.35%)
Prelude Therapeutics Incorporated (PRLD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 211.99M |
| Enterprise value | -4.05M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.89 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.03 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.50 |
| 52-week change 3 | -37.36% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 6.8800 |
| 52-week low 3 | 1.6600 |
| 50-day moving average 3 | 4.4198 |
| 200-day moving average 3 | 3.6078 |
Share statistics
| Avg vol (3-month) 3 | 67.21k |
| Avg vol (10-day) 3 | 41.22k |
| Shares outstanding 5 | 42.07M |
| Implied shares outstanding 6 | 54.93M |
| Float 8 | 13.63M |
| % held by insiders 1 | 9.04% |
| % held by institutions 1 | 96.32% |
| Shares short (15 Apr 2024) 4 | 604.04k |
| Short ratio (15 Apr 2024) 4 | 14.72 |
| Short % of float (15 Apr 2024) 4 | 4.54% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.10% |
| Shares short (prior month 15 Mar 2024) 4 | 643.17k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -33.19% |
| Return on equity (ttm) | -56.33% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -131.11M |
| Net income avi to common (ttm) | -121.83M |
| Diluted EPS (ttm) | -2.0200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 232.94M |
| Total cash per share (mrq) | 4.24 |
| Total debt (mrq) | 16.89M |
| Total debt/equity (mrq) | 7.12% |
| Current ratio (mrq) | 10.79 |
| Book value per share (mrq) | 4.32 |
Cash flow statement
| Operating cash flow (ttm) | -107.06M |
| Levered free cash flow (ttm) | -58.93M |
© 2024 Yahoo. All rights reserved.